Cleared Traditional

Revitalair 430F

K171899 · Oxavita Srl · Anesthesiology
Nov 2019
Decision
879d
Days
Class 2
Risk

About This 510(k) Submission

K171899 is an FDA 510(k) clearance for the Revitalair 430F, a Chamber, Hyperbaric (Class II — Special Controls, product code CBF), submitted by Oxavita Srl (Buenos Aires, AR). The FDA issued a Cleared decision on November 22, 2019, 879 days after receiving the submission on June 26, 2017. This device falls under the Anesthesiology review panel. Regulated under 21 CFR 868.5470.

Submission Details

510(k) Number K171899 FDA.gov
FDA Decision Cleared SESE
Date Received June 26, 2017
Decision Date November 22, 2019
Days to Decision 879 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF

Device Classification

Product Code CBF — Chamber, Hyperbaric
Device Class Class II — Special Controls
CFR Regulation 21 CFR 868.5470

Similar Devices — CBF Chamber, Hyperbaric

All 68
FESL FINK Chamber; FEDL FINK Chamber; FETL FINK Chamber
K240569 · Fink Engineering Pty, Ltd. · Nov 2024
Revitalair 430+
K220290 · Us Hyperbaric Network · May 2023
OxyHeal 4000 Multiplace Hyperbaric Chamber Family
K163109 · Oxyheal Medical Systems, Inc. · Mar 2017
Rectangular Multiplace Hyperbaric Chamber System Product Family with Touchscreen Control System
K152223 · Oxyheal Medical Systems, Inc. · Apr 2016
SECHRIST MONOPLACE HYPERBARIC OXYGEN CHAMBER
K140559 · Sechrist Industries, Inc. · May 2014
RSI 4200
K102831 · Reimers Systems, Inc. · Aug 2011